Letting Seriously Ill Patients Try Drugs Whose Safety, Efficacy Hasn’t Been Proven Could Be Deadly

Forbes, 20 January 2017
Author: Rita Rubin
“The new FDA report, released practically on the eve of President Donald Trump’s inauguration, challenges critics who want to make drugs available to patients as soon as possible. It includes several examples of drugs and vaccines that had a favorable effect on biomarkers–measurable indicators of health, such as blood cholesterol levels–but did not improve symptoms or reduce the risk of a disease.”
Find article here.